Have Marc Coucke and co-shareholder Waterland Omega Pharma sold far too expensive? And was there fraud involved? In a nutshell, that is the question that three ‘arbitrators’ – reputable business lawyers – will have to answer in the coming weeks. A lot is at stake for Coucke: Perrigo is demanding 1.9 billion euros. And no appeal is possible against the decision of the arbitration board.
Flashback to the end of 2014: Marc Coucke sells Omega Pharma, the company he co-founded and grew up himself, to the American pharmaceutical giant Perrigo for an equivalent amount of 3.8 billion euros. A sample amount …
Source link by https://www.nieuwsblad.be/cnt/dmf20201026_96021846
*The article has been translated based on the content of Source link by https://www.nieuwsblad.be/cnt/dmf20201026_96021846
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!
These were the details of the news Marc Coucke and Perrigo compete for 1.9 billion euros: Om … for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at news1.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
